Cargando…

In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations

Liver fibrosis is a common result of liver injury owing to various kinds of chronic liver diseases. A deeper understanding of the pathophysiology of liver fibrosis and identifying potential therapeutic targets of liver fibrosis is important because liver fibrosis may progress to advanced liver disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Young-Sun, Seki, Ekihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444957/ https://www.ncbi.nlm.nih.gov/pubmed/37270060 http://dx.doi.org/10.1016/j.jcmgh.2023.05.010

Ejemplares similares

Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets
por: Kim, Jieun, et al.
Publicado: (2023)

Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms
por: Yang, Ling, et al.
Publicado: (2012)

Toll-Like Receptor Signaling and Liver Fibrosis
por: Aoyama, Tomonori, et al.
Publicado: (2010)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2023)

Acrolein, a New Villain in the Development of Alcoholic Liver Disease
por: Seki, Ekihiro
Publicado: (2016)

TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis
por: Seki, Ekihiro
Publicado: (2014)

TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis
por: Wang, Weijun, et al.
Publicado: (2021)

Origin of myofibroblasts in liver fibrosis
por: Brenner, David A, et al.
Publicado: (2012)

Nuclear Receptors: Opening Up New Avenues of Pediatric Fatty Liver Research
por: Pandyarajan, Vijay, et al.
Publicado: (2018)

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2010)

Alcoholic liver disease: A current molecular and clinical perspective()
por: Ohashi, Koichiro, et al.
Publicado: (2018)

Basic and Clinical Advances in Chronic Liver Inflammation
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Intestinal Lipolysis Mitigates Nonalcoholic Fatty Liver Disease: New Roles for Carboxylesterase 2c in the Intestine
por: Pimienta, Michael, et al.
Publicado: (2019)

In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations
por: Kaur, Savneet, et al.
Publicado: (2022)

Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms
por: Yin, Fei, et al.
Publicado: (2019)

Limitations of non-invasive tests for assessment of liver fibrosis
por: Patel, Keyur, et al.
Publicado: (2020)

Toll-Like Receptor Signaling in Liver Diseases
por: Szabo, Gyongyi, et al.
Publicado: (2010)

Current investigations into the genotoxicity of zinc oxide and silica nanoparticles in mammalian models in vitro and in vivo: carcinogenic/genotoxic potential, relevant mechanisms and biomarkers, artifacts, and limitations
por: Kwon, Jee Young, et al.
Publicado: (2014)

A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1
por: Czech, Torrey Y., et al.
Publicado: (2018)

Tumor Suppressor Down-Regulation Promotes Hepatocyte Proliferation: A New GANKster on the Block
por: Pimienta, Michael, et al.
Publicado: (2018)

Crossing the Rubicon: Adipose Tissue Autophagy Breaks Out NAFLD
por: Kim, Jieun, et al.
Publicado: (2021)

The roles and mechanisms of hypoxia in liver fibrosis
por: Cai, Jingyao, et al.
Publicado: (2021)

Kupffer Cell TLR2/3 Signaling: A Pathway for EGCG Amelioration of Ethanol-Induced Hepatic Injury
por: Czech, Torrey Y., et al.
Publicado: (2019)

GIV/Girdin is a central hub for pro-fibrogenic signalling networks during liver fibrosis
por: Lopez-Sanchez, Inmaculada, et al.
Publicado: (2014)

TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice
por: Yang, Ling, et al.
Publicado: (2017)

Non-invasive in vivo Imaging Grading of Liver Fibrosis
por: Jiang, Hanyu, et al.
Publicado: (2018)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Using human induced pluripotent stem cell-derived liver cells to investigate the mechanisms of liver fibrosis in vitro
por: Koui, Yuta, et al.
Publicado: (2023)

In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus
por: Lotti, Roberta, et al.
Publicado: (2022)

The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application
por: Zhang, Danyan, et al.
Publicado: (2022)

The Roles and Mechanisms of lncRNAs in Liver Fibrosis
por: He, Zhi, et al.
Publicado: (2020)

Antifibrotic Effect of Marine Ovothiol in an In Vivo Model of Liver Fibrosis
por: Brancaccio, Mariarita, et al.
Publicado: (2018)

Adverse Effects of Bisphenol A on the Liver and Its Underlying Mechanisms: Evidence from In Vivo and In Vitro Studies
por: Abdulhameed, Al-Salihi Ahmed Rashid, et al.
Publicado: (2022)

Graptopetalum paraguayense Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro
por: Hsu, Wei-Hsiang, et al.
Publicado: (2019)

Mechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis
por: Chakraborty, Jayashree Bagchi, et al.
Publicado: (2012)

Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis
por: Wang, Gaiping, et al.
Publicado: (2023)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
por: Pinheiro, Daphne, et al.
Publicado: (2019)

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
por: Caligiuri, Alessandra, et al.
Publicado: (2021)

In Vitro and In Vivo Models to Study Nephropathic Cystinosis
por: Cheung, Pang Yuk, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qeklci3tgk5a49gp68ol6aav06